Diagnostic, Therapeutic and Reproductive Aspects of Patients with Mullerian Anomalies
Launched by UNIVERSITY HOSPITAL, GHENT · Nov 9, 2020
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding Mullerian anomalies, which are conditions that affect the development of female reproductive organs, including the uterus, vagina, and cervix. The researchers want to explore how these anomalies can lead to reproductive issues and complications during pregnancy. By studying these conditions, they aim to find better ways to diagnose and treat women who have them.
To participate in this trial, women must be aged 45 or younger and have a uterus with a Mullerian anomaly. Unfortunately, women without a uterus or those over 45 years old are not eligible. Participants can expect to undergo various assessments to help doctors gather important information about their condition, and they will be contributing to valuable research that could improve care for many women in the future. If you or someone you know meets the eligibility criteria, this could be an important opportunity to help advance our understanding of these conditions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women with a uterus
- • presence of a mullerian variation
- • Maximum age 45y
- Exclusion Criteria:
- • women without a uterus
- • aged \>45y
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Trial Officials
Tjalina Hamerlynck
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials